You just read:

SeaStar Medical to Initiate a Pilot Study of Selective Cytopheretic Device in COVID-19 patients with Acute Respiratory Distress Syndrome and Acute Kidney Injury

News provided by

SeaStar Medical

Apr 28, 2020, 09:10 ET